Upload
phungminh
View
221
Download
1
Embed Size (px)
Citation preview
Index
β-Hydroxy acyl-CoA dehydrogenase (β-HAD),117
Álvarez-Sánchez, B., 216, 21713C labelling, 242, 245, 2472-Hydroxyisobutyric acid (α-HB), 2302D difference gel electrophoresis (DIGE), 1975-(Tetradecyloxy)-2-furoic acid (TOFA), 141
AAarsland, A., 33Abderrahmani, A., 93Aboka, F.O., 245Abrams, G.A., 44Abumrad, N., 117Abuoun, M., 282Accurate mass tag (AMT), 189Acetyl-CoA carboxylase (ACC), 32, 141Achten, J., 116Ackermann, A.M., 92Adachi, J., 197Adamian, L., 309Adams, J.M., 118Adaptive mechanism, 5, 228Adiels, M., 35, 161–163, 165–167Adipocentric model, 6, 8, 9Adipocyte, 7, 9–13, 32, 33, 38, 41, 64–66,
68–73, 75, 124, 177, 178, 197, 198, 202,224, 226, 228, 308
Adipokines, 12, 42, 43, 65, 66, 198Adiponectin, 7, 9, 12, 41–43, 65, 66, 68, 69,
71–75, 139, 166, 198Adipose tissue, 7–12, 29, 32, 33, 36–38, 40–43,
64–66, 69–75, 95, 113, 117, 124, 125,144, 147, 158, 172, 174, 178, 196–198,202, 203, 224, 225, 227, 228, 230, 257,259, 306, 343, 344, 357, 358, 362
as an endocrine organ, 197as biomarker, 252
as energy storage organ, 12fat deposition in, 14fatty acids (FAs) in, 342, 343lipolysis in, 226protein recovery, 197
Adipose tissue expandability, 64Adipose tissue expandability hypothesis, 10Adipose tissue inflammation, 12, 14Adlercreutz, H., 259Aebersold, R., 188Aggio, R.B., 222Agoram, B., 356Aguer, C., 118Aguirre, V., 114Ahima, R.S., 66Ahmed, M., 202Ahrens, C.H., 187, 188Ai, Z.L., 37Aittoniemi, J., 304Akesson, M., 286, 294Alaiya, A., 188Alberti, K.G., 3, 4, 86, 93Albu, J.B., 342Alexander, C.A., 166Alkhalaf, A., 201Allet, N., 192Allison, C., 255Allostasis, 5Allostatic adaptations, 4in homeostasis maintenances, 5
Allostatic load, 6Altomonte, J., 32Alwine, J.C., 149Amacher, D.E., 188Amaral, A.I., 245AMP-activated protein kinase (AMPK), 35,
142–144, 173Analysis of Variance (ANOVA), 325, 330–335
M. Orešic, A. Vidal-Puig (eds.), A Systems Biology Approach to Study Metabolic Syndrome, 367DOI 10.1007/978-3-319-01008-3, © Springer International Publishing Switzerland 2014
368 Index
Anandamide (AEA), 177, 178Andersen, T., 46Anderson, E.J., 125Andersson, U., 143, 144Andreasen, M.F., 266, 267Andrews, Z.B., 140, 150Andrikopoulos, S., 99Anello, M., 94Angelico, F., 166Angelin, B., 39Angiogenesis, 12, 66Angulo, P., 44Anthocyanins, 260, 267–269Antoniewicz, M.R., 243, 244Apolipoproteins, 38, 158, 162Appeldoorn, M.M., 265Arabidopsis thaliana, 283, 291Arachidonic acid, 11, 227, 228, 306, 308Aranibar, N., 220Arcuate nucleus (ARC), 138Arita, Y., 69, 71Ariyama, Y., 147Armoni, M., 343Arner, P., 10, 113Arvidsson, E., 203Asensio-López, M.C., 69, 74Aston-Mourney, K., 99Athyros, V.G., 41Aura, A.-M., 253, 255, 256, 258–261, 265, 268Austin, R.C., 145Autophagy, 13, 86, 96, 97Avram, M.M., 65Avruch, J., 230Ayton, G.S., 300, 301
BBäckhed, F., 172–174Bò, C.D., 269Babushok, V.I., 220Bach Knudsen, K.E., 259Bach, D., 121, 122Backhed, F., 173Bacon, B.R., 43Bahceci, M., 64Bai, N., 253Bajaj, M., 343Balkau, B., 28Bandyopadhyay, G.K., 114Banerjee, R.R., 70Banks, R.E., 196Bar-Joseph, Z., 333, 337Barbier, O., 37Bard scoring system, 45
Barrett, P.H., 164Barroso, I., 122Barry, J.L., 255, 256Barter, P.J., 226Basseri, S., 145Bateman, R.H., 193Bates, S.H., 66Bateson, M.C., 39Baxter, C.J., 244Baynes, J.W., 291Bazzocco, S., 256, 265Bearne, C.A., 255Beavis, R.C., 187, 189Becker, S.A., 294Befroy De, P.K., 119, 121Beil, U., 39Bell, G.D., 39Bell, K.S., 114Benani, A., 140Bendall, S.C., 194, 195Benjamini, Y., 320, 326Benzoic acid, 261, 265, 267, 269Berg, A.H., 69Berg, J.M., 282Bernal-Mizrachi, C., 40Bernroider, E., 30Beta-cell, 86, 88–100Beynon, R.J., 190Billin, A.N., 42Bilu, Y., 286Bilz, S., 39Bing, C., 227Bioinformatics, 204, 314Birnbaum, M.J., 114Birner-Gruenberger, R., 197Bischof, M.G., 30Bjork, E., 99Bjornholm, M., 113Bjursell, M., 177Blaak, E.E., 120Blood brain barrier (BBB), 140Bluher, M., 69Bock, K., 291Bodary, P.F., 68Boden, G., 30, 33, 71, 90, 118, 147Bogardus, C., 114Boirie, Y., 124Bonadonna R.C., 115Bonadonna, R.C., 112, 115Bondarenko, P.V., 192Bonen, A., 117, 118Boni-Schnetzler, M., 90, 95Bonner-Weir, S., 99
Index 369
Bookout, A.L., 37Boren, J., 161, 166, 240, 242Boschetti, E., 189Bothwell, J.H., 238Bouche, C., 89Boura-Halfon, S., 113Boushel, R., 118, 119, 122Bouskila, M., 116Bouwman, F.G., 203Bouzakri, K., 113Boyko, E.J., 68Boyle, J.G., 74Braithwaite, S.S., 114Brakenhielm, E., 12Brand-Miller, J., 71Bratchell, N., 334Braune, A., 267Breiman, L., 328Briaud, I., 91Broder, S., 187Brody, E.N., 194, 195Brown adipose tissue (BAT), 12, 144, 176Brown fat oxidization, 14Brown, M.S., 32Brown, N.F., 117Brown, R.J., 98Brown, W.V., 32Browning, J.D., 33, 35, 37, 44Bruce, C.R., 118Bruce, K.D., 63, 65Bruggeman, F.J., 239Brunham, L.R., 93Brunner, Y., 199Brunt scoring system, 45Brunt, E.M., 45Bruss, M.D., 114Bruun, J.M., 71, 72Bugianesi, E., 29, 30, 42, 166Burgess, S.C., 241Busch, A.K., 91Butler, A.E., 88, 96Byrne, C.D., 28, 63, 65
CCaballero, F., 34Cabrero, A., 41Caesar, R., 174, 227Cairns, R.A., 292Caldwell, S.H, 29, 166Cales, P., 45Calle, E.E., 138Calvo, S.E., 199Campbell, J., 117
Campbell, W.L., 255Campfield, L.A., 149Cani, P.D., 174, 177, 257Cannon, B., 144Cantor, R.S., 310, 311Cao, G., 38Cao, Y., 12Capeau, J., 28, 32, 34, 42Carbohydrate response element-binding protein
(ChREBP), 33–35, 172Cardio-metabolic syndrome, 64Cardiovascular disease (CVD), 157
risks of, 27, 157, 162Carey, P.E., 114Cargile, B.J., 189Cariou, B., 39Carling, D., 138, 141, 142Carlsson, C., 230Carnitine palmitoyltransferase (CPT) system,
117Caron, S., 32Carpentier, A., 90, 165Carpentier, A.C., 90Carulli, N., 39Carvalho, C., 336Cascante, M., 238–240Castillo, S., 220Castro-Perez, J.M., 237Catalase, 94Celeux, G., 332Cell surface-capturing (CSC) technology, 195Central nervous system (CNS), 138Ceramides, 10, 13, 15, 118, 227Cerda, B., 259, 260Cevallos-Cevallos, J.M., 270Cha, J.Y., 38Chakravarthy, M.V., 40Chan, D.C, 162, 163, 166, 167Chang, X., 36Charles, M.A., 28Chatziioannou, A., 282Chawla, A., 38Chelius, D., 192Chen, D.F., 37Chen, H., 121Chen, K., 162Chen, M., 32Chen, S., 114Chen, W., 63Chen, X., 90Chenodeoxycholic acid (CDCA), 38, 39Chernomordik, L.V., 308Chibalin, A.V., 113
370 Index
Chinetti, G., 40, 41Chisari, V., 291Choi, J., 243Choi, J.H., 70, 73Choi, S.E., 97Cholesterol ester transport protein (CETP), 35,
40, 158, 161Cholic acid (CA), 38Choudhury, A.I., 89Christesen, H.B., 99Chromatography, 190, 217, 220Chun, T.H., 13Chylomicrons, 32, 35, 158, 174, 357Claret, M., 145Clark, J.M., 166Claudel, T., 39Claus, S.P., 175, 176Clayton, J.J., 175Clayton, T.A., 175Clifford, M.N., 268Cline, G.W., 115Clustering, 325, 326, 332, 333Cnop, M., 90, 98, 147CNS-related symptoms, 149Coarse-grained modelling, 301–303, 305, 315Cohen, J.C., 224Cohn, J.S., 32Colas, R., 93Colberg, S.R., 120Colinge, J., 187, 189Collins, H., 198Collins, J.M., 241Colonic metabolism, 252, 253Combs, T.P., 69, 72Computed tomography (CT), 44, 45Computer simulation, 300, 303Conrads, T.P., 189Consoli, A., 121Constraint-based modeling (CBM), 222,
282–285, 289, 291, 294Contreras, F.X., 303, 309Coronary heart disease (CHD), 162, 224Corpeleijn, E., 120Corton, M., 197Costanzo-Garvey, D.L., 144Costello, E.K., 171Cota, D., 138, 148Crabb, D.W., 34, 36Craig, R., 187, 189Crawford, P.A., 172Crouse, J.R., 39Cunha, D.A., 147Curien, G., 239
Curto, R., 239Cusi, K., 121Cyranoski, D., 196Czech, A., 342
Dda Silva Xavier, G., 91Dagenais, G.R., 116Damian, D., 324, 326Damsbo, P., 114, 116Danforth, E., Jr., 65Daran-Lapujade, P., 286Dashti, N., 35Data integration, 320, 336–338Davis, D.B., 93Day, A.J., 258Day, C., 43Day, C.P., 42, 43, 46De Atauri, P., 239De Ferranti, S., 64, 65De Feyter, H.M., 119De Graaf, A.A., 164De Mello, V.D.E., 252, 253De novo lipogenesis (DNL), 33, 39, 43, 138,
141, 164, 172Defronzo, R.A., 111, 112Del Guerra, S., 94Del Prato, S., 116Delepine, M., 98Delghingaro-Augusto, V., 99Denechaud, P.D., 34Deng, S., 94Deng, W.J., 199Deng, Y., 65, 66, 69, 198Dent, P., 115, 116Depréz, S., 255, 265Deshpande, R., 244Despres, J.P., 65Dettmer, K., 217, 220Di Marzo, V., 177Di Nardo, A., 149Diabetes, 3, 44, 65, 68, 69, 86, 89, 97, 98,
100, 121, 123, 147, 178, 196, 199, 200,226, 228
animal model, 98, 200biomarkers of, 200onset of, 95risk of, 27, 93, 224
Diacylglycerol (DAG), 10, 13, 15, 118, 125,227
Diehl, A.M., 166Dietary fibre (DF), 252, 253, 255, 256Ding, S., 173Dixon, J.B., 46
Index 371
DNA aptamers, 195Doege, H., 33Dohm, G.L., 112, 115Doliba, N.M., 94Dominguez-Bello, M.G., 171Dominiczak, M.H., 291Domon, B., 187Donath, M.Y., 95Donnelly, K.L., 32, 43Donovan, J.L., 259Dor, Y., 88Dorsomedial nucleus (DMH), 139, 141Dowell, P., 141, 142Dowman, J.K., 43Draznin, B., 113Drew, B.G., 93Dry fractionation, 267Duarte, N.C., 222, 282, 286, 290Dube, M.G., 252Dudley, E., 237Duffaut, C., 71Duggan G.E., 225Durot, M., 282Duval, C., 38Duvillard, L., 167Dyck, D.J., 118Dyslipidaemia, 3, 10, 157, 162Dzamko, N., 145
EEbato, C., 97Eckel, R.H., 3, 4, 251Edvardsson, U., 202Edwards, C.A., 255Edwards, J.S., 282, 285Edwards, P.A., 38Efron, B., 329Eguez, L., 114Ehses, J.A., 95Eizirik, D.L., 98, 145–147Ek, J., 122El Assaad, W., 147El Ouaamari, A., 88El-Assaad, W., 90Electrospray ionisation (ESI), 186Elias, J.E., 190Ellingsgaard, H., 95Elmquist, J.K., 66, 138, 139Elouil, H., 147EMC remodelling, 13Endo, H., 149Endoplasmic reticulum stress (ER stress), 6,
13, 36, 71, 86, 98, 99, 140, 145–148,150, 201
in hypothalamus, 150obesity-induced, 148oxidative-induced, 149
Eng, J.K., 189Engelmann, B., 228Epididymal adipose tissue (EWAT), 227ER dysfunction, 147ER-to-Golgi protein traffikopus01kkcking, 98Eriksson, J., 112, 115Escribano, O., 88Esposito, K., 75Evans, J.L., 230Evans, K., 357Everard, A., 257Everett-Grueter, C., 343Everhart, J.E., 44
FFabbrini, E., 35, 166Fahy, E., 226Fain, J.N., 68Faine, L.A., 73Falck-Ytter, Y., 43Famili, I., 285, 286Fan, T.W., 245Fan, X., 145Farooqi, I.S., 138Farsenoid X receptor
bile acid (BA) conjugation, 38FXR-α, 38, 39FXR-β, 38
Fatty acid binding proteins (FABPs), 33Fatty acid oxidation (FAO), 30, 66, 116–120,
141, 144, 173, 227in mitochondrial matrix, 36
Fatty acid transport protein (FATP), 33Fatty acids (FAs), 29, 65, 71, 72, 90, 91, 95–98,
117–119, 124, 125, 140, 141, 158, 161,203, 213, 219, 226, 227, 230, 252,309, 342
impaired β-oxidation of, 29Fausto, N., 291Fawcett, K.A., 122Federici, M., 94Feist, A.M., 240, 282Felber, J.P., 342Felgines, C., 259Felig, P., 225, 226, 228Fernandez-Alvarez, J., 94Fernandez-Miranda, C., 41Ferrannini, E., 114Ferre, P., 30, 34Ferulic acid dimers, 267Fex, M., 94
372 Index
Fiehn, O., 226, 231Fisher, R., 331Flavanols, 260, 261Flavonoid glycosides, 258Fleissner, C.K., 173Fleschhut, J., 268Flier, J.S., 138Fluxome, 238Fluxomics, 238, 240, 246, 247Folger, O., 292Fong, S.S., 285, 286Fontes, G., 90–92, 99, 199Ford, E.S., 64Foretz, M., 34Forman, B.M., 40Forrester, S.C., 269Foster, L.J., 191Foufelle, F., 30, 34Free fatty acids (FFAs), 32, 36, 43, 147, 226Frenkel, D., 301, 303Frezza, C., 292Fridlyand, L.E., 230Friedman, J.M., 66, 138Fruhbeck, G., 138Fu, S., 201Fuller, N., 308Funahashi, T., 70
GGaglio, D., 241Galgani, J.E., 120Galisteo, M., 74, 252Gall, W.E., 231Gangabadage, C.S., 167Gao, Q., 138, 139Gao, Z., 114Garfinkel, D., 282Gartner, C.A., 191Gas chromatography (GC), 217, 219–221, 243Gastaldelli, A., 30, 35Gauthier, M.S., 33Gaziano, T.A., 157Geer, L.Y., 187Gelman, A., 331Genomics, 186, 200, 204Gerber, S.A., 190German, M.S., 96Geromanos, S.J., 193Ghouri, N., 44Ghrelin, 139Gil-Izquierdo, A., 253Giles, T.D., 72Gille, C., 294
Gillet, L.C., 193Ginsberg, H.N., 32Girard, J., 34Glaser, B., 99Glass, C.K., 12, 124Glitazones, 72Glucolipotoxicity, 86, 90, 91
concept of, 90Glucose metabolism, 30, 34, 37, 39, 41, 75, 87,
94, 112, 114, 119, 174, 176, 177, 225,226, 228, 252
gluconeogenesis, 30glycogen synthesis, 112, 115, 224glycogenolysis, 30
Glucosinolates, bioconversion of, 256GLUT4 trafficking, 114Glutathione peroxidases (GPx), 94Glycogen, 30, 32, 34, 111, 224, 244, 343Godsland, I.F., 68Golay, A., 342Golbidi, S., 94Gold, L., 194, 195Goldstein, J.L., 32Gonthier, M.-P., 265, 267Goodacre, R., 282Goodlett, D.R., 191Goodyear, L.J., 112, 113Gordon, J.I., 172Goto, S., 282Gottlicher, M., 40Grün, C.H., 260Grass, G., 356Grattagliano, I., 46, 252Greco, D., 33Green tea, epigallocatechin gallate, 253, 261Green, R., 226Green, R.M., 29, 32Greenberg, A.S., 72Greiner, T., 173Griffin, J.L., 238Grill, V., 99Grill, V.E., 99Gronwald, W., 216Groop, L.C., 112Gropper, S., 291Gross, M., 259Grundy, S.M., 63, 65Gu, L., 247Gudmundsson, S., 240Guettier, J.M., 32Gustafsson, J.A., 37Gut microbiota, 171–178, 213Gutierrez, A., 39
Index 373
Gutierrez-Juarez, R., 68Guyton, A.C., 259Gwiazda, K.S., 98Gygi, S., 186, 191Gygi, S.P., 190
HHaataja, L., 96Habener, J.F., 147Hagman, D.K., 91, 92Halaas, J.L., 66, 197Hall, A., 305Hall, J.E., 68Halliwell, B., 230Halvatsiotis, P., 124Hamaguchi, M., 29Hamilton, J.A., 117Han, X.X., 118Hanahan, D., 292Handschin, C., 123Hanhineva, K., 260Hanke, S., 199Hansen, B.T., 189Hara, K., 122Harano, Y., 41Harder, H., 266Haring, R., 44Harrison, S.A., 45Hashimoto, N., 89Hashimoto, T., 40Hattori, M., 257Havel, R.J., 162He, F., 291He, M., 342He, W., 141Hegarty, B.D., 118Heijtz, R.D., 174Hein, E.-M., 259Heinonen, S., 259Heinrich, R., 239Hemery, Y., 267Henquin, J.C., 88Henry, O., 243Hepatic steatosis, 8, 28, 29, 32–34, 40–42,
44, 177Hepatitis B virus, 149Herder, C., 86Hernandez-Alvarez, M.I., 121Hess, B., 282, 303Hickman, I.J., 46High-density lipoprotein (HDL), 8, 28Higuchi, N., 34, 36, 37Hiller, K., 243
Hirasawa, A., 343Hirokane, H., 39Hirosumi, J., 71, 114Hiukka, A., 167Hochberg, Y., 320, 326Hoehn, K.L., 125Hoene, M., 95Hojlund, K., 199Holland, W.L., 227Holloway, G.P., 118, 119Holman, R.R., 86Holmes, E., 213Homeostasis model of assessing insulin
resistance (HOMA-IR), 166Hoofnagle, A.N., 196Hoppa, M.B., 91Hoppel, C., 117Horai, H, 221Horikawa, Y., 35Hormone-sensitive lipase (HSL), control of, 33Horton, J., 30, 35Horton, J.D., 33, 35Horvath, T.L., 138, 139Hosoi, T., 147, 148, 150Hotamisligil, G.S., 71, 145Hotta, K., 69Houstis, N., 125, 230Hoy, A.J., 118Hsich, G., 188Hu, Q., 187, 188Hu, Z., 141, 142Huang, C.J., 147Hubbard, S.R., 145–147Hui, J.M., 42Human metabolic model, 282, 289, 290Human Proteome Organisation (HUPO), 196Human Proteome Project (HPP), 196Hummel J, 221Humpf, H.U., 268Hunte, C., 309Huopaniemi, I., 323, 335, 337Huopio, H., 99Hwang, H., 199Hyötyläinen, T., 217, 220, 231Hydroxycinnamic acids, 260, 266, 267Hyperglycemic-hyperinsulinemic clamp, 112,
114Hypertension, 9, 28, 63–65, 68, 69, 72, 114,
224, 226, 251Hypertriglyceridaemia, 8Hypothalamus, 4, 66, 138, 140, 141, 143,
147–150Hypoxia, 13, 214
374 Index
IIbarra, R.U., 285Ibarrola, N., 191Ide, T., 34Iizuka, K., 35Ikemoto, S., 176Imai, J., 88In vitro digestion models, 252, 255, 256, 258,
265–269, 292, 294Inada, A., 88Inflammation, 11–13, 37, 40–43, 45, 46, 63,
70–72, 75, 86, 90, 95, 124, 148, 174,197, 228, 251, 252, 257
Insulin, 5Insulin exocytosis, 88, 93
late stages of, 91Insulin resistance, 3–5, 8–10, 12–14, 28,
30, 63, 65, 69–73, 86, 88, 89, 92,93, 97–100, 112, 116–118, 120,121, 123–126, 138, 140, 166, 176,196, 199, 202, 224, 226–228, 230,251, 257
FA induced, 65in muscle, 125pathogenesis of, 114
Insulin resistance syndrome, 64Insulin sensitivity, 7, 12, 13, 29, 34, 39, 41, 46,
47, 66, 68–70, 72, 93, 113, 121–123, 174in muscle, 126
Insulin signaling, 30, 41, 69, 112, 113,122–124
Insulin-mediated glucose disposal (IMGD), 8Interferon gamma (IFNγ), 71Interleukins (ILs)
IL-1, 7IL-1β, 95, 124IL-10, 124IL-13, 124IL-6, 71, 124IL-8, 124
Iozzo, P., 227Ippel, J.H., 191Ishihama, Y., 192Islet, 86, 90–96, 98, 99, 147, 198, 199, 203Islet amyloid polypeptide (IAPP), 96Isoelectric focussing (IEF), 193Isomaa, B., 63Isotopic steady state, 243, 244Isotopologue, 221, 242–244Isotopomer, 242–245
mass isotopomer, 243positional isotopomer, 243
Itani, S.I., 114, 118
JJacobs, D.M., 260Jacobs, J.M., 198Jacqueminet, S., 91James, O., 43James, O.F., 42, 43, 46Jamshidi, N., 282Janowski, B.A., 37Janson, J., 96Jansson, A., 225Jensen, M.D., 65Jensen, M.O., 309Jensen, O.N., 187Jensen, P.A., 294Jerby, L., 222, 289, 290, 294Jheng, H.F., 122Jiang, G., 41Jin, H.O., 149Jonas, J.C., 99Joseph, S.B., 38Joshi, A., 282Jouhten, P., 245Joy, D., 44Jung, H.S., 70, 97Juntunen, K.S., 259
KKaaks, R., 138Kabashima, T., 35Kadowaki, T., 68Kahn, B.B., 138, 141, 142, 145, 173Kahn, S.E., 114Kaiser, H.J., 309Kalaany, N.Y., 37Kallwitz, E.R., 41Kalt, W., 259, 269Kamerlin, S.C.L., 301Kamin, D., 70Kanehisa, M., 282Kaneko, K., 89Kankainen, M., 222, 329Karaskov, E., 98Karlsson, H.K., 114, 115Kase, E.T., 38Kashyap, S., 90Kast, H.R., 39Kasuga, M., 89Katajamaa, M., 221Katz, A., 342Kau, A.L., 178Kauffman, K.J., 285Kaufman, R.J., 71, 98Kaushik, S., 97
Index 375
Kawaguchi, T., 35Keay, S., 71Keller, A., 187, 190Kelley, D.E., 114, 116, 118–122, 343Kelpe, C.L., 90, 91Keppler, K., 268Kern, S.M., 259Kerner, J., 117Kersten, S., 40, 41Khan, T., 13Kharroubi, I., 36Kiens, B., 117Kilkkinen, A., 259, 260Kim, D.-H., 259Kim, E.K., 141Kim, J.K., 114Kim, J.Y., 73, 118, 119, 343Kim, Y.B., 68, 113Kind, T., 220Kinetic modeling, 282Kirkpatrick, S., 245Kissebah, A.H., 226Kitamura, T., 124Klein, H.H., 113Kliewer, S.A., 40Knust, U., 259Kobashi, K., 259Kobayashi, H., 68Koivuniemi, A., 312Koli, R., 268Kondo, H., 68Koo, S.H., 40Kopka, J., 220Korchak, H.M., 33Korenblat, K.M., 29Koseki, M., 93Kotronen, A., 224, 227Koves, T.R., 119Kozlitina, J., 33Kozlov, M.M., 308Krömer, J., 238, 240Kraegen, E.W., 29Kraft, C.S., 123Kramer, D., 41Kratchmarova, I., 197Krebs cycle, 87, 94, 117, 121, 216, 226, 240,
242, 292Krijgsveld, J., 191Krook, A., 113, 114Kroon, P.A., 266Kruger, M., 197Kruit, J.K., 93Kruszynska, Y.T., 115
Kubota, N., 89Kuchel, P.W., 237, 247, 282Kuhajda, F.P., 141Kuijsten, A., 253, 259Kulkarni, R.N., 89Kullin, M., 99Kumar, V.S., 282Kumari, S., 221Kuster, B., 186, 190Kusunoki, J., 230Kyriakis, J.M., 230
LLópez, M., 138, 139, 141–145, 150Laaksonen, D.E., 226Lachin, J.M., 39Lackner, C., 45Lada, A.T., 161Lafay, S., 253, 258Laffitte, B.A., 38Lage, R., 138, 143, 145Lam, T.K., 140, 141, 149Lambert, G., 39Lamers, D., 198Lampe, J.W., 259, 260Lane, A.N., 238, 243Lane, M.D., 147Langsrud, O., 334Lanne, B., 197Lanpher, B., 222Lanz, R.B., 37Larsen, C.M., 95Larsen, T.M., 203Larter, C.Z., 29, 32Las, G., 97Lasonder, E., 192Lateral hypothalamic area (LHA), 139Laurin, J., 41Lavoie, J.M., 33Laybutt, D.R., 98, 99, 147Le Foll, C., 149Le, H.-S., 337Leahy, J.L., 99Lee, F.Y., 39Lee, I.-D., 282Lee, J.K., 222Lee, M.-J., 261Lee, S.S., 40Legrain, P., 196Lehr, S., 66Lehrke, M., 70Leibowitz, M.D., 41Leiss, O., 39Lelliott, C.J., 123
376 Index
Leloup, C., 94Lemieux, S., 165Lentz, J.S., 28, 43Lenzen, S., 94Leone, T.C., 123Leptin, 12, 43, 66, 68, 139, 144, 145, 198
role of, 66Leptos, K.C., 192Lescuyer, P., 187, 188Levine, D.M., 286Lewis, G.F., 43, 343Ley, R.E., 172Leyva, F., 68Li, H., 192Li, L., 253Li, R.X., 200Li, W., 243, 247Li, X., 230Li, Y., 114Li, Z., 166Li, Z.Z., 34Liesa, M., 123Lin, E., 342Lin, J., 123Lin, J.H., 145–147Lin, Y., 253Lindén, D., 162Lingwood, D., 303–305, 309Lipid induced toxicity
deleterious effects of, 10Lipid membrane, 228, 300, 301, 303, 304, 308,
310Lipid metabolism, 29, 30, 34, 41, 44, 66, 72,
73, 75, 116, 118, 163, 197, 201, 224,226, 228, 253, 313, 315
homeostasis of, 33, 34, 40in skeletal muscles, 126mechanism of, 141regulation of, 117
Lipid metabolism, in muscle, 125Lipid spillover, 342–344, 357, 362Lipid-sensing NRs, 37Lipoprotein, 30, 32, 35, 38, 41, 158, 161, 162,
165–167, 227, 300, 301, 312, 314, 315,342, 344, 345, 362, 364
Lipoprotein metabolism, 163, 164Lipoprotein, catabolism of, 164Lipotoxic hypothesis, 125Lipotoxicity, 7, 13, 34, 43, 90, 137, 145, 150,
203Lipotoxicity, in muscle, 125Lipson, K.L., 147Lisacek, F., 190
Listgarten, J., 332Liu, H.B., 192Liu, L., 68Liu, M., 73Liver, 7, 11, 12, 14, 15, 28–30, 32–42, 44, 66,
68, 70, 72, 88, 121, 158, 161, 166, 172,173, 175, 176, 224, 226, 230, 253, 257,258, 267, 269, 282, 283, 289–291, 294,312, 342–344
Liver biopsy, 45Liver X receptors (LXRs), 37–39
cholesterol homeostasis, 37, 38, 93, 176in bile acid metabolism, 37, 176, 291in FA metabolism, 38in glucose metabolism, 38in macrophages, 37, 38LXRs genes, 37
Liver, Kuppfer cells, 125Llaneras, F., 239Lodish, H.F., 117Loftus, T.M., 141, 142, 150Lonard, D.M., 37Long, Y.C., 145Lopez, C.A., 89, 303Lorenzo, C., 63Lorkowski, S., 237Louhivuori, M., 301Lu, Y., 337Lucero, D., 35Ludwig, J., 28, 44Luiken, J.J., 118Lundbak, J.A., 310Luo, Y., 38Lusis, A.J., 86
MMöller, D.E., 251Ma, H., 282Ma, K., 39Ma, Y., 252Ma, Z., 96Maassen, J.A., 230MacBeath, G., 188Macfarlane, G.T., 256Madiraju, S.R., 90Maeda, N., 41, 69, 71, 72Maedler, K., 91, 95Maegawa, H., 113Magkos, F., 166Magnetic resonance imaging (MRI), 43–45Mahadevan, R., 240, 286, 288Maher, A.D., 239Mahley, R.W., 158Maier, B., 95
Index 377
Makishima, M., 38Malet-Martinoa, M., 220Mallick, P., 186, 190Malmstrom, R., 166Malonyl-CoA decarboxylase (MCD), 141Mammalian target of rapamycin (mTOR), 97,
148Mandard, S., 173Mandarino, L.J., 116, 119Mangelsdorf, D.J., 37–39Mann, M., 188, 189, 199Maranas, C.D., 282Marc, J., 64Marchesini, G., 29, 166Mari, A., 89Marin, S., 238, 240, 242Marrero, J.A., 29Marrink, S.J., 301, 303, 305Marsh, B.J., 97Marsh, D., 309Martínez de Morentin, P.B., 144Martin, F.P., 176Martin, T.L., 144Martins, L., 148Masini, M., 97Maslowski, K.M., 177Mass spectrometry (MS), 186, 190, 194, 204,
217, 243Mateo Anson, N., 266Mathews, C., 282Matrix-assisted laser desorption/ionisation
(MALDI), 186, 189, 190, 216Matsuoka, Y., 238, 240Matsuzawa, Y., 65Matteoni, C.A., 28, 29, 44Matthiesen, R., 187, 189, 190, 192Matveyenko, A.V., 96Mayer, J., 149Mayerson, A.B., 41McCarthy, D.J., 326, 333McClain, C.J., 46McCrimmon, R.J., 143, 145McCullough, A.J., 43, 166McGarry, J.D., 117McGillicuddy, F.C., 71McKenna, N.J., 37Mckusick, V.A., 291Medina-Gomez, G., 138Meier, J.J., 88Meijer Twh, K.J., 292Membrez, M., 174Meng, X., 261Menshikova, E.V., 123
Mertens, I., 70Meselhy, M.R., 261Metabolic Analysis Tool (iMAT), 282, 286–289Metabolic flexibility, 119–121, 204Metabolic networks, 178, 238–240Metabolic phenotypic analysis (MPA), 292,
294Metabolic Syndrome (MetS), 3, 4, 6, 9, 44,
63–65, 68–70, 72, 86, 88, 90, 93, 97, 99,100, 116, 138, 224, 246, 247, 251, 252,260, 270, 303, 308, 311, 315, 341–344
metabolic biomarkers of, 230pathogenesis of, 27, 28, 37, 64, 252treatment of, 41, 46, 72
Metabolomics, 178, 186, 213–217, 219, 220,222, 231, 238, 247, 269, 291, 320, 329
Metallo, C.M., 238, 240, 241Metalloproteases (MMPs), 13Metformin (N,N-dimethylimidodicarbonimidic
diamide hydrochloride)beneficial effect of, 73
Metz, T.O., 198Michael, M.D., 88Microsomal transfer protein (MTP), 35, 36,
161Midtvedt, T., 176Milbury, P.E., 259, 269Miller Dm, T.S., 292Miller, J.C., 140Miller, M., 32, 33Miller, N.E., 39Miller, T.L, 255Mingrone, G., 121Minokoshi, Y., 68, 141, 143, 144, 150Misra, P., 73Mitochondrial dysfunction, 36, 65, 86, 94, 121,
123, 125, 126, 199, 229, 230Mitogen-activated protein kinases (MAPKs),
113Mittendorfer, B., 33Mlinar, B., 64Moco, S., 219Model Building Algorithm (MBA), 282, 283,
289–292Mogensen, M., 122Mohamed-Ali, V., 71Molecular dynamics simulation, 228, 300, 304,
306, 310, 312Molly, K., 256Monticelli, L., 303Moore, P.C., 90, 91Mootha, V.K., 119, 122, 199Moreno-Sanchez, R., 239
378 Index
Morgan, K., 140, 149Mori, H., 149Mori, M., 145–147Morino, K., 121Moro, C., 118Morton, G.J., 138, 139Mostertz, W., 323Mouritsen, O.G., 300Mozaffarian, D., 64, 65Muccioli, G.G., 177, 178Mueller, L.N., 192Mulquiney, P.J., 282Multi-way experimental design, 320, 322, 323,
329, 330, 333, 334, 337, 338Multidimensional protein identification
technology (MudPIT), 189Muoio, D.M., 95Murtola, T., 301, 302, 314Muscelli, E., 342Muscle, 7, 11, 14, 15, 36, 42, 72, 113–116,
118–125, 144, 199, 224, 230, 294, 342,344
Muse, E.D., 70Musso, G., 29Musunuru, K., 29Myers, M.G., 66Myers, R.P., 45
NNakahara, M., 39Nakamuta, M., 34, 36, 41Namikawa, C., 36Nanjo, F., 261Natsume, M., 259Navarro, P., 193Nedergaard, J., 144Neels, J.G., 11Nemeth, K., 258Nesbitt, P.D., 259Nestel, P.J., 39Nesvizhskii, A.I., 187, 190Nettleton, J.A., 252Neumann, S., 221Neuschwander-Tetri, B.A., 46, 166Newberry, E.P., 33Newgard, C.B., 95, 225Newsholme, P., 94Neyrinck, A.M., 75Ng, S.K., 332Nguyen, M.T., 114, 124Nickerson, J.G., 117Niemann-Pick C1-like 1 (NPC1L1), 38Niemelä, P.S., 306
Nikerel, I.E., 239Nikkilä, J., 323Nilsson, A.C., 75, 138Nogi, T., 309Noh, K., 244Nolan, J.J., 113Nolte, R.T., 40Nonalcoholic fatty liver disease (NAFLD), 14,
28, 29, 32–37, 40–46, 166, 203, 227pathogenesis of, 42treatment of, 44, 46
Nonalcoholic steatohepatitis (NASH), 28, 36,41–46
prevalence of, 44Norbeck, A.D., 189Nordlund, E., 267Nuclear magnetic resonance (NMR), 217, 220,
222, 224, 243, 260Nuclear receptors (NRs), 36Nurmi, T., 268Nuutila, P., 111Nygren, H., 219
OO’Malley, B.W., 37O’Rahilly, S., 138O’Rourke, R.W., 71Oberhardt, M.A., 282Obese non-diabetic vs. lean individuals, 88Obesity, 3, 6, 7, 9–15, 30, 41–44, 63–66,
68–73, 75, 95, 112, 113, 115, 118–124,138, 140, 144, 145, 147–149, 157,166, 172–174, 176–178, 196, 198, 199,201–203, 214, 224–231, 342
prevalence of, 6, 138Obesogenic environment, 6Obici, S., 142, 149, 150Oh, M.K., 44Okamoto, Y., 75Okita, M., 46Olefsky, J.M., 11, 12, 124Oliver, W.R., 41Ollila, O.H.S., 310, 311Ollila, S., 310Olofsson, C.S., 91Olofsson, S.O., 161Olthof, M.R., 267Olufadi, R., 28Omics data, 320, 322–328, 330, 332–338Onate, S.A., 37Ong, S.E., 191Oprescu, A.I., 90Ordinary differential equations (ODE) system,
245
Index 379
Orešic, M., 226, 320Oresic, M., 237Orth, J.D., 239, 240Ortqvist, E., 99Orvall, M., 226Osei-Hyiaman, D., 177Otte, K., 38Ouchi, N., 68, 69, 75Ouguerram, K., 167Oxidative stress, 36, 42, 43, 72, 90, 94, 199,
214, 229, 230, 251, 294Oyadomari, S., 145–147Ozcan, L., 147, 148, 150Ozcan, U., 36, 71, 149
PPól, J., 216Pajvani, U.B., 69, 73Palagi, P.M., 192Palmblad, M., 189Palsdottir, H., 309Palsson, B.O., 240, 282, 285, 286, 294Pan, W., 328Panchaud, A., 191, 193, 194Pancreas-duodenum homeobox-1 (Pdx-1), 91Pancreatic beta cell, functions of, 86, 99, 100,
198, 199Paolisso, G., 94, 230Papin, J.A., 294Paraventricular nucleus (PVH), 138, 139, 141,
143Parkhomenko, E., 336Parks, D.J., 38Parks, E.J., 33Parton, D.L., 310Pastucha, D., 342Patel, C., 70Patel, L., 70, 75Patsouris, D., 125Pattern recognition receptor, 174Patterson, B.W., 164, 165Patti, M.E., 119, 121, 122Paul Lee, W.N., 238, 240, 243Pawlikowska, P., 123Pealvo, J., 256Pedersen, B.K., 115Peet, D.J., 37Pende, M., 114Peng, J., 190Pennuto, M., 147Pentose-phosphate pathway, 231, 242Peppercorn, M.A., 267Peptide mass sequencing (PMS), 189
Peptide match score summation (PMSS), 192Perez-Perez, R., 197Peripheral energy homeostasis
defects in, 4Perkins, D.N., 189, 190Peroxisome proliferator-activated receptor
(PPARS), 37as fatty acid sensors, 40isoforms of, 40
PPAR-α, 40, 42, 199, 202PPAR-β, 40, 41PPAR-δ, 40, 41PPAR-γ, 40, 41
Petersen, K.F., 32, 33, 72, 119, 121Petta, S., 43Pettersson, J., 260Peyot, M.L., 93, 94Pfeiffer, A.F.H., 252Phenolic acids, 253, 258–260, 266–268Philipson, L.H., 230Phillips, J.C., 303Phosphatidylinositol 3-kinase (PI3K), 113Phosphoenolpyruvate carboxykinase (PEPCK),
30Phosphofructokinase (PFK), 116Pi, J., 94Pich, S., 121Pico, J., 239Pietiläinen, K., 224, 227, 228, 306Pietilainen, K.H., 11Pigeon, E., 342Pineda, T.I., 39Pirola, L., 113Pittas, A.G., 72Plasminogen activator inhibitor 1 (PAI-1)
thrombosis, 70Plum, L., 138Plumb, G.W., 266Pocai, A., 140, 149Poitout, V., 90, 94Pollin, T.I., 33Polyunsaturated fatty acids (PUFAs), 34, 308Pontiroli, A.E., 98Pospisilik, J.A., 123Postic, C., 34Powell, E.E., 28Poynard, T., 45Pratt, J.M., 190Prawitt, J., 176Pre-diabetes, 64Prendergast, G.C., 292Prentki, M., 90, 342Press, W., 245
380 Index
Preston, A.M., 98Priebe, M.G., 252Prieur, X., 12Primary hyperinsulinaemia, 4Principal Component Analysis (PCA), 325,
327, 328, 330, 335Prior, R.L., 267Proanthocyanidin, 260, 261, 265, 266Proopiomelanocortin (POMC), 139, 145, 149Protein abundance indices (PAIs), 192Protein kinase A (PKA), 34Proteomics, 178, 186–188, 190, 192–194, 196,
197, 199–203, 247, 294, 320Proulx, K., 148Psychogios, N., 222Ptacek, J., 188Pullinger, C.R., 35Pyruvate dehydrogenase (PDH), 116
QQatanani, M., 70, 230Qi, D., 96Qi, J., 142Qi, K., 140Qi, L., 75Qiao, L.Y., 114Qin, J., 172Quantum mechanics (QM), 301Quek, L.E., 245Quinn, C.E., 72Qvigstad, E., 99
RRabe, K., 66Rabinowitz, J.D., 97Rabot, S., 173, 174Radtke, M., 99Raftos, J.E., 239Rahmouni, K., 68Rajilic-Stojanovic, M., 257Ralf, J.M., 221Ramadurai, S., 310Rand, R.P., 308Randle, P.J., 30, 226Rao, M.S., 230Rao, P.V., 200Rapoport, S.I., 140Rappsilber, J., 192Rashid, S., 158Raymond, F., 188Reactive oxygen species (ROS), 13, 36, 125,
230Reasner, C.A., 72Reaven, G.M., 88, 226
Rechner, A.R., 259Reddy, J.K., 40, 230Reid, B.M., 44Reigstad, C.S., 174Reilly, M.P., 70Reimann, F., 176Reinhardt, C., 171Repa, J.J., 37, 38Resistin, 7, 69, 124, 139, 198
function of, 70in macrophages, 70inhibitory role of, 70
Riaz, S., 202Ribon, V., 41Righetti, P.G., 189Rinella, M.E., 29, 32Riserus, U., 41Risselada, H.J., 305Ritov, V.B., 121, 122Rizki, G., 29, 32Robbins, R.D., 95Roberts, M.S., 259Robertson, R.P., 90, 94, 95Rocha, V.Z., 71Roden, M., 30, 86Rodriguez-Prados, J.C., 239, 241Rog, T., 300, 305Romeo, S., 44Romero, P., 282Ron, D., 145–147Rondini, L., 266Rondinone, C.M., 227Ronti, T., 66, 68, 70Roowi, S., 261Rosen, P., 230Ross, P.L., 191Rother, K.I., 98Rothman, D.L., 115, 116Rubio-Aliaga, I., 203Rudel, L.L., 161Ruderman, N.B., 138, 141, 142Ruhl, C.E., 44Rumney, C.J., 255Rupnick, M.A., 12Ruppin, E., 239Rutti, S., 93Ryder, J.W., 112
SSaadeh, S., 44Saberi, M., 174Sadee, W., 291Saier, M.H., Jr., 291
Index 381
Saisho, Y., 88Sako, Y., 99Salek, R.M., 324Sampaio, J.L., 303Sampson, M.J., 118Samuel, B.S., 177Samuel, V.T., 29Sanchez, J.C., 197, 202Sander, G.E., 72Sanders, S.L., 192Sano, H., 114Sanyal, A.J., 29, 35, 36, 41, 44–46, 227Sarafidis, P.A., 72, 138Satoh, H., 70Sauer, U., 238Savage, D.B., 41, 70, 227Savkur, R.S., 39, 40Sawai, Y., 253, 259Scalbert, A., 258, 266Schaffer, J.E., 117Schapansky, J., 147Schattenberg, J.M., 29, 32Scheline, R.R., 261Schellenberger, J., 286Schena, M., 188Schenk, S., 113, 124Scherer, P.E., 65, 69, 73, 198Scherl, A., 194Scheuner, D., 98Schilling, C.H., 222, 240, 286, 288Schlatzer, D.M., 200Schmidt, A., 191Schmidt, M., 291Schnell, S., 343Schoenfield, L.J., 39Schonfeld, P., 230Schoonjans, K., 40Schrauwen-Hinderling, V.B., 119, 123Schreiber, S.L., 188Schrimpe-Rutledge, A.C., 199Schroder, M., 71Schuler, M., 123Schuster, S., 239, 240, 286Schwieterman, W., 117Schwudke, D., 219Schymanski, E.L., 221Seeram, N.P., 253, 259Segre, D., 285Selivanov, V.A., 238, 240, 241, 243–245Selma, M.V., 253Semple, R.K., 69Semplici, F., 91Seo, D.M., 324, 337
Serkova, N.J., 225Serotonin, 175Shah, A., 40Shah, O.J., 114Shaheen, A.A., 45Sharma, N.K., 147Shaw, D.E., 301Shaw, R.J., 73Shepherd, J., 39Shi, H., 41Shih, D.M., 39Shimano, H., 34Shimizu, K., 238, 240Shimomura, I., 34Shklyaev, S., 42Shlomi, T., 222, 282, 285, 286, 294Shmueli, O., 291Shotgun approach, 219Shulman, A.I., 37Shulman, G.I., 33, 112, 114Sierra-Honigmann, M.R., 68Silva, R.M., 147Simoneau, J.A., 118–121Simons, K., 303, 304Sinal, C.J., 39, 176Singh, L.P., 201Single-cell mass cytometry, 195Single-nucleotide polymorphisms (SNPs), 32Slot Van’T, G., 265Smilde, A.K., 334Smit, B., 301, 303Smith, C.A., 221Smith, C.E., 252Smith, L., 291Smyth, G., 333Smyth, G.K., 326, 333Sohda, T., 40Song, B., 147Sonoda, J., 123Sorensen, A., 141Sorensen, L.P., 167Soriano, F.X., 123Sotgia, F., 292Sozio, M., 34, 36Spalding, K.L., 10Spiegelman, B.M., 40Spranger, J., 95Sprecher, D.L, 41Spruijt-Metz, D., 75Srour, O., 245Stable-isotope dilution (SID), 191Staehr, P., 343Staels, B., 40
382 Index
Stalmach, A., 261Stannard, S.R., 342Starkey, J.M., 202Statistical analysis, 222, 245, 322, 324, 334,
338Stauber, R.E., 45Stefan, N., 69Steffensen, K.R., 37Stenson, B.M., 38Step-by-step algorithm (SBSA) model, 345Stephanopoulos, G., 239Stephens, J.M., 71Stephenson, J.L., Jr., 189Steppan, C.M., 69, 70Sterol regulatory element binding proteins
(SREBPs), 33, 34Stillemark, P., 161Stillemark-Billton, P., 161Stote, K.S., 253Stoupi, S., 265Strissel, K.J., 71Stump, C.S., 124Sturek, J.M., 93Subramanian, A., 329Suganami, T., 65Summers, S.A., 13Sumner, L.W., 32, 221Sundaram, M., 32Sunny, N.E., 227Sunyaev, S., 189Superoxide dismutase enzymes (SOD), 94Surinova, S., 188Suss, C., 198Suvitaival, T., 337Swann, J.R., 176, 177Syka, J.E., 188, 191Syndrome X, 64Sysi-Aho, M., 324, 333, 336, 337Systems biology, 3, 175, 178, 186, 203, 204,
239, 320, 338Szmitko, P.E., 69
TTabb, D.L., 189Tabernero, M., 255, 256Tai, F., 328Takagaki, A., 261Takahashi, M., 68Takata, Y., 41Talchai, C., 99Tamada M.S.M., 292Tamura, S., 34Tan, P.-N., 328
Tanaka, T., 41Tanaka, Y., 95Tang, Q.Q., 10, 147Tangier disease, 93Taniguchi, C.M., 113Targher, G., 166Taskinen, M.R., 157, 158, 162, 166, 167Taube, A., 113Taylor, C.A., 64Taylor, T.D., 257Teli, M.R., 28Terämä, E., 311Teusink, B., 239Theodoridis, G.A., 217, 219Theodorou, G., 70Thiazolidinediones (TZDs), 40
beneficial effects of, 72in T2DM patients, 41, 72side effects of, 72, 73
Thiebaud, D., 116Thiele, I., 240Thomas, C., 39, 176Thompson, C.B., 292Thong, F.S., 114Thrush, A.B., 118Tibshirani, R., 328, 329Tilton, R.G., 199Toledo, F.G., 121, 123Tonooka, N., 94Tontonoz, P., 38–40Torti, F.M., 71Towle, H.C., 32, 34Tracer studies, 112Trawick, J.D., 222Trayhurn, P., 227Treatment of
obesity with diabetes, 15Tremblay, F., 228Triacylglycerols hydrolysis, 197Tricarboxylic acid (TCA) cycle�see also Krebs
cycle, 119Triglycerides (TGs), 28, 312Trim, P.J., 216Trimethylamines (TMA), 176Tripathi, A., 337Triple-quadrupole (QqQ) mass spectrometer,
218Trygg, J., 328, 336Tryptophan metabolism, 175Tuberous sclerosis complex (TSC), 149Tucker, K.L., 252Tulenko, T.N., 32Tumour necrosis factor α (TNFα), 7, 71, 124
Index 383
Turnbaugh, P.J., 171, 172, 174, 258Turner, N., 119Turrens, J.F., 94Type 1 diabetes mellitus (T1DM), 30, 98, 320,
337Type 2 diabetes mellitus (T2DM), 3, 4,
30, 42, 43, 63–65, 68, 69, 71–73,75, 86, 98, 112, 113, 115, 116,118–122, 124, 138, 158, 162, 166, 167,198–200, 224, 230, 251, 320, 327,335, 341
UUm, S.H., 114Unfolded protein response (UPR), 36, 98, 146Unger, R.H., 7, 29, 65Uribe, A., 175Urizar, N.L., 39
VVacca, M., 39Vaitheesvaran, B., 247van den, B.T., 149van Gunsteren, W.F., 302Vander Heiden, M.G., 292Vapnik, V., 328Varela, L., 148Varghese, S.A., 201Varma, A., 285Vattulainen, I., 300, 310–312Velagapudi, V.R., 172, 175Venema, K., 256Verchere, C.B., 96Vergeer, M., 93Very low density lipoprotein (VLDL),
30, 32, 35, 38, 39, 41, 42, 158,161, 162, 164–167, 172, 176, 224,226, 231
assembly of, 32, 35, 161catabolism of, 158impaired secretion of, 36overproduction of, 32regulators of, 161, 162synthesis of, 35
Verzelloni, E., 253Vestergaard, H., 116Vianna, C.R., 123Vidal-Puig, 138Vidal-Puig, A., 5, 7, 138Vijay-Kumar, M., 174Villarreal-Molina, M.T., 93Viollet, B., 145Virtue, S., 5Visser, M., 252
Vitaglione, P., 268Vizan, P., 242VLDL–triglyceride metabolism, 164Vo, T.D., 282von Eckardstein, A., 93Von, B.K., 39Voth, G.A., 300, 301Vrieze, A., 213
WWagner, M., 38, 39Wajchenberg, B.L., 68Waki, H., 68, 69Walder, K., 122Wall, R., 257Wallace, D.C., 199Wallace, J.M., 41Walle, T., 258Walter, P., 145–147Wang, A.P., 68, 72Wang, H., 38, 71Wang, L., 39, 329Wang, P., 203Wang, Q.M., 201Wang, R., 149Wang, T.J., 228Wang, Y., 32, 39, 201, 226Wang, Y.X., 41, 123Wang, Z., 176Wang, Z.V., 73Wanless, I.R., 28, 43Ward, P.S., 292Washburn, M.P., 189Watada, H., 96Watanabe, M., 39, 176Waterhouse, A.L., 269Watt, M.J., 118Way, J.M., 41Webb-Robertson, B.-J.M., 334, 337Wei, Y., 36Weickert, M.O., 252Weigert, C., 95Weinberg, R.A., 292Weir, G.C., 99Wellen, K.E., 71West, M., 320, 336Westerbacka, J., 32, 227Westerhuis, J., 329Westermark, G.T., 96Westermark, P., 96White adipose tissue, 177, 227White, E., 97White, M.F., 112, 114
384 Index
Whiting, D.R., 86Whittle, A.J., 144Wiback, S.J., 282, 285Wiechert, W., 243–245Wikoff, W.R., 175Wilander, E., 96Williams, K.J., 162Willy, P.J., 37Wilm, M., 189Wilson-Fritch, L., 73Wishart, D.S., 222, 258, 291Woerle, H.J., 112Wojtczak, L., 230Wolcott-Rallison syndrome, 98Wold, S., 328, 336Wolf, S., 221Wolfe, R.R., 33Wolfgang, M.J., 142, 150Wolfinger, R., 332Wolfrum, C., 34Wollscheid, B., 194, 195Won, J.C., 148, 150Woods, S.C., 148Wopereis, S., 227Wostmann, B.S., 176Wredenberg, A., 123Wright, K.S., 114Wu, C., 216Wu, C.C., 191Wu, C.Z., 342Wu, M.C., 330Wu, Z., 41Wyne, K.L., 65
XXenobiotic metabolism, 175Xenobiotics, 247Xia, J., 222Xie, M., 142Xu, A., 42Xu, H., 71Xu, J., 172, 247Xu, Y., 221Xue, B., 144
YYamauchi, T., 68, 69Yan, Q., 291Yanai, I., 286, 291Yang, H., 71Yang, J.C., 149Yang, L., 145Yang, L.V., 227Yannakoulia, M., 75Yanting, W., 302Yao, Z., 32Yeagle, P.L., 303Yetukuri, L., 301, 312, 313, 335Yki-Jarvinen, H., 115, 224Yoshida, K., 173You, M., 41, 42Youssef, W., 166Yu, C., 118Yuan, M., 114Yusta, B., 147
ZZahorska-Markiewicz, B., 252Zamboni, N., 238, 245Zeigerer, A., 114Zelcer, N., 39Zhang, D., 202Zhang, G.F., 247Zhang, H., 92, 93Zhang, X., 147, 148, 150Zhang, Y., 38–40, 66Zhao, Z., 258Zhen, Y., 189Zhou, G., 73Zhou, H., 198Zhou, J., 33, 38Zhou, L., 73Zick, Y., 113Zierath, J.R., 115, 145Zimmet, P., 68, 157Zoltowska, M., 32Zraika, S., 96Zubarev, R.A., 189Zucker diabetic fatty rat, 95Zur, H., 294